$522 Million is the total value of Rhenman & Partners Asset Management AB's 108 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 21.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | New | Gilead Sciences Inc | $18,611,000 | – | 259,894 | +100.0% | 3.57% | – |
| BMY | Buy | Bristol Myers Squibb Co | $16,422,000 | -99.9% | 281,000 | +18.6% | 3.15% | +55.1% |
| AGN | Sell | Allergan Plc | $15,961,000 | -99.9% | 76,000 | -4.4% | 3.06% | +5.2% |
| LLY | Sell | Eli Lilly & Co | $15,813,000 | -99.9% | 215,000 | -15.7% | 3.03% | -6.8% |
| MDT | New | Medtronic Plc | $15,332,000 | – | 215,240 | +100.0% | 2.94% | – |
| INCY | Sell | Incyte Corp Ltd | $14,038,000 | -99.9% | 140,000 | -24.3% | 2.69% | -2.9% |
| TEVA | Buy | Teva Pharma Ind Ltd ADR repr 1 Share | $13,050,000 | -99.9% | 360,000 | +33.3% | 2.50% | +26.8% |
| EXEL | Buy | Exelixis Inc | $12,375,000 | -99.8% | 830,000 | +38.3% | 2.37% | +94.6% |
| UNH | Sell | United Health Group Inc | $12,006,000 | -99.9% | 75,017 | -42.3% | 2.30% | -20.4% |
| ABMD | Buy | Abiomed Inc | $11,572,000 | -99.9% | 102,700 | +20.8% | 2.22% | +27.8% |
| HZNP | Buy | Horizon Pharma Plc | $11,326,000 | -99.8% | 700,000 | +91.8% | 2.17% | +106.6% |
| ALXN | Sell | Alexion Pharmaceuticals Inc | $11,220,000 | -99.9% | 91,702 | -43.3% | 2.15% | -31.6% |
| ARIA | Buy | Ariad Pharmaceuticals Inc | $11,134,000 | -99.9% | 895,000 | +32.6% | 2.13% | +45.4% |
| CVS | Sell | CVS Health Corp | $11,047,000 | -99.9% | 140,000 | -12.5% | 2.12% | -6.3% |
| PFE | New | Pfizer Inc | $10,826,000 | – | 333,300 | +100.0% | 2.08% | – |
| CELG | Sell | Celgene Corp | $10,765,000 | -99.9% | 93,000 | -50.0% | 2.06% | -33.2% |
| BIIB | Sell | Biogen Inc | $10,209,000 | -99.9% | 36,000 | -36.8% | 1.96% | -30.9% |
| REGN | Sell | Regeneron Pharmaceuticals Inc | $9,728,000 | -99.9% | 26,500 | -10.2% | 1.86% | -1.0% |
| AMGN | Buy | Amgen Inc | $9,504,000 | -99.9% | 65,000 | +18.2% | 1.82% | +25.1% |
| CI | Sell | Cigna Corp | $9,204,000 | -99.9% | 69,000 | -17.9% | 1.76% | +1.4% |
| CNC | Buy | Centene Corp | $8,477,000 | -99.8% | 150,000 | +87.5% | 1.62% | +91.0% |
| ANTM | New | Anthem Inc | $8,376,000 | – | 58,257 | +100.0% | 1.61% | – |
| ZBH | Sell | Zimmer Biomet Hgs Inc | $8,256,000 | -99.9% | 80,000 | -5.9% | 1.58% | -9.8% |
| HUM | Buy | Humana Inc | $8,161,000 | -99.8% | 40,000 | +60.0% | 1.56% | +122.9% |
| HCA | Sell | HCA Holdings Inc | $7,750,000 | -99.9% | 104,707 | -4.8% | 1.49% | +12.5% |
| AET | Buy | Aetna Inc | $7,689,000 | -99.8% | 62,000 | +47.6% | 1.47% | +91.4% |
| ESRX | Express Scripts Hg Co | $7,636,000 | -99.9% | 111,000 | 0.0% | 1.46% | +17.8% | |
| ABBV | Buy | AbbVie Inc | $7,201,000 | -99.9% | 115,000 | +4.5% | 1.38% | +25.2% |
| EW | Buy | Edwards Lifesciences Corp | $6,559,000 | -99.9% | 70,000 | +27.3% | 1.26% | +19.4% |
| NVRO | Buy | Nevro Corp | $6,490,000 | -99.9% | 89,314 | +81.2% | 1.24% | +52.3% |
| HOLX | Sell | Hologic Inc | $6,419,000 | -99.9% | 160,000 | -11.1% | 1.23% | +10.9% |
| TMO | Buy | Thermo Fisher Scientific Inc | $6,350,000 | -99.8% | 45,000 | +80.0% | 1.22% | +92.6% |
| SUPN | Sell | Supernus Pharmaceuticals Inc | $6,313,000 | -99.9% | 250,000 | -7.4% | 1.21% | +14.0% |
| XNCR | Xencor Inc | $5,922,000 | -99.9% | 225,000 | 0.0% | 1.14% | +29.7% | |
| JAZZ | Sell | Jazz Pharmaceuticals Plc | $5,552,000 | -99.9% | 50,920 | -15.1% | 1.06% | -8.1% |
| ZLTQ | Sell | ZELTIQ Aesthetics Inc | $5,440,000 | -99.9% | 125,000 | -21.9% | 1.04% | +4.6% |
| ABC | Buy | AmerisourceBergen Corp | $5,317,000 | -99.9% | 68,000 | +28.3% | 1.02% | +49.9% |
| DXCM | Buy | Dexcom Inc | $5,063,000 | -99.9% | 84,800 | +30.5% | 0.97% | +7.3% |
| ALNY | Buy | Alnylam Pharmaceuticals Inc | $5,054,000 | -99.9% | 135,000 | +3.8% | 0.97% | -30.7% |
| NKTR | Buy | Nektar Therapeutics | $5,031,000 | -99.9% | 410,000 | +5.1% | 0.96% | -9.4% |
| ENDP | Sell | Endo International Plc | $4,944,000 | -99.9% | 300,200 | -16.7% | 0.95% | -17.8% |
| ARRY | Array BioPharma Inc | $4,835,000 | -99.9% | 550,000 | 0.0% | 0.93% | +57.1% | |
| VRTX | Sell | Vertex Pharmaceuticals Inc | $4,790,000 | -99.9% | 65,013 | -18.7% | 0.92% | -17.1% |
| CAH | Buy | Cardinal Health Inc | $4,678,000 | -99.9% | 65,000 | +18.2% | 0.90% | +32.1% |
| LBIO | Lion Biotechnologies Inc | $4,518,000 | -99.9% | 650,000 | 0.0% | 0.87% | +1.9% | |
| ITCI | Buy | Intra-Cellular Therapies Inc | $4,376,000 | -99.8% | 290,000 | +114.8% | 0.84% | +156.6% |
| RVNC | Revance Therapeutics Inc | $4,347,000 | -99.9% | 210,000 | 0.0% | 0.83% | +54.0% | |
| ALKS | Sell | Alkermes Plc | $4,202,000 | -99.9% | 75,599 | -56.9% | 0.81% | -38.6% |
| NXTM | Buy | NxStage Medical Inc | $4,165,000 | -99.9% | 158,901 | +9.4% | 0.80% | +38.3% |
| BMRN | Sell | BioMarin Pharmaceutical Inc | $4,142,000 | -100.0% | 50,000 | -64.3% | 0.79% | -61.4% |
| MRK | Sell | Merck & Co Inc | $4,121,000 | -100.0% | 70,000 | -65.0% | 0.79% | -60.1% |
| OMCL | Omnicell Inc | $4,018,000 | -99.9% | 118,537 | 0.0% | 0.77% | +6.8% | |
| GKOS | Buy | Glaukos Corp | $3,972,000 | -97.9% | 115,800 | +2170.6% | 0.76% | +2354.8% |
| LH | Laboratory Corp of America Hgs | $3,851,000 | -99.9% | 30,000 | 0.0% | 0.74% | +12.7% | |
| LIVN | New | Livanova Plc | $3,598,000 | – | 80,000 | +100.0% | 0.69% | – |
| KITE | Sell | Kite Pharma Inc | $3,587,000 | -99.9% | 80,000 | -11.1% | 0.69% | -13.8% |
| ESPR | Buy | Esperion Therapeutics Inc | $3,443,000 | -99.8% | 275,000 | +111.5% | 0.66% | +130.8% |
| ELGX | Buy | Endologix Inc | $3,289,000 | -99.9% | 575,000 | +32.2% | 0.63% | -28.6% |
| UHS | Universal Health Services Inc B | $3,191,000 | -99.9% | 30,000 | 0.0% | 0.61% | +4.3% | |
| MGNX | Buy | Macrogenics Inc | $3,168,000 | -99.9% | 155,000 | +10.7% | 0.61% | -8.7% |
| Sell | NeuroDerm Ltd | $3,165,000 | -99.9% | 142,546 | -1.4% | 0.61% | +43.2% | |
| CHRS | Sell | Coherus BioSciences Inc | $3,135,000 | -99.9% | 111,357 | -15.2% | 0.60% | +7.5% |
| RIGL | Sell | Rigel Pharmaceuticals Inc | $3,051,000 | -99.9% | 1,282,000 | -8.4% | 0.58% | -28.3% |
| DVA | Sell | DaVita Inc | $2,889,000 | -99.9% | 45,000 | -18.2% | 0.55% | -4.0% |
| PTLA | Portola Pharmaceuticals Inc | $2,711,000 | -99.9% | 120,805 | 0.0% | 0.52% | +19.3% | |
| TSRO | Sell | Tesaro Inc | $2,690,000 | -99.9% | 20,000 | -7.0% | 0.52% | +50.9% |
| KERX | Sell | Keryx Biopharmaceuticals Inc | $2,491,000 | -99.9% | 425,111 | -15.0% | 0.48% | +13.3% |
| FGEN | FibroGen Inc | $2,226,000 | -99.9% | 104,000 | 0.0% | 0.43% | +24.9% | |
| ADMS | Adamas Pharmaceuticals Inc | $2,197,000 | -99.9% | 130,000 | 0.0% | 0.42% | +24.2% | |
| ICPT | Buy | Intercept Pharmaceuticals Inc | $2,173,000 | -99.9% | 20,000 | +100.0% | 0.42% | +59.8% |
| RDUS | Sell | Radius Health Inc | $2,092,000 | -99.9% | 55,000 | -26.7% | 0.40% | -37.7% |
| PRGO | Sell | Perrigo Co Plc | $2,081,000 | -99.9% | 25,000 | -28.6% | 0.40% | -22.2% |
| WBA | Sell | Walgreens Boots Alliance Inc | $2,069,000 | -100.0% | 25,000 | -61.5% | 0.40% | -52.3% |
| ACAD | Buy | Acadia Pharmaceuticals Inc | $2,019,000 | -99.9% | 70,000 | +40.0% | 0.39% | +53.0% |
| ILMN | New | Illumina Inc | $1,921,000 | – | 15,000 | +100.0% | 0.37% | – |
| DVAX | Buy | Dynavax Technologies Corp | $1,916,000 | -99.9% | 485,000 | +61.7% | 0.37% | -26.6% |
| CMRX | Sell | Chimerix Inc | $1,840,000 | -99.9% | 400,000 | -27.3% | 0.35% | -27.1% |
| HALO | Sell | Halozyme Therapeutics Inc | $1,778,000 | -99.9% | 180,000 | -28.0% | 0.34% | -29.0% |
| NBIX | Neurocrine Biosciences Inc | $1,548,000 | -99.9% | 40,000 | 0.0% | 0.30% | -7.8% | |
| AERI | New | Aerie Pharmaceuticals Inc | $1,325,000 | – | 35,000 | +100.0% | 0.25% | – |
| PODD | Sell | Insulet Corp | $1,319,000 | -99.9% | 35,000 | -38.6% | 0.25% | -31.8% |
| TTPH | Tetraphase Pharmaceuticals Inc | $1,209,000 | -99.9% | 300,000 | 0.0% | 0.23% | +27.5% | |
| RGLS | Buy | Regulus Therapeutic Inc | $1,053,000 | -99.9% | 468,175 | +56.1% | 0.20% | +28.7% |
| BDX | New | Becton Dickinson & Co | $828,000 | – | 5,000 | +100.0% | 0.16% | – |
| ACHN | Sell | Achillion Pharmaceuticals Inc | $686,000 | -100.0% | 166,000 | -37.6% | 0.13% | -61.4% |
| MD | Mednax Inc | $600,000 | -99.9% | 9,000 | 0.0% | 0.12% | +21.1% | |
| TNDM | Tandem Diabetes Care Inc | $503,000 | -100.0% | 234,000 | 0.0% | 0.10% | -66.3% | |
| ADVM | Adverum Biotechnologies Inc | $447,000 | -99.9% | 154,006 | 0.0% | 0.09% | -14.9% | |
| MYL | New | Mylan N.V. | $382,000 | – | 10,000 | +100.0% | 0.07% | – |
| CATB | Catabasis Pharmaceuticals Inc | $361,000 | -99.9% | 100,000 | 0.0% | 0.07% | -29.6% | |
| JPM | Buy | JPMorgan Chase & Co | $353,000 | -99.8% | 4,087 | +52.0% | 0.07% | +142.9% |
| WFC | Buy | Wells Fargo & Co | $337,000 | -99.8% | 6,118 | +35.3% | 0.06% | +103.1% |
| OCUL | Ocular Therapeutix Inc | $335,000 | -99.9% | 40,000 | 0.0% | 0.06% | +45.5% | |
| STAA | New | Staar Surgical Co | $312,000 | – | 28,711 | +100.0% | 0.06% | – |
| CNCE | Concert Pharm Inc | $310,000 | -99.9% | 30,099 | 0.0% | 0.06% | +22.9% | |
| MSFT | Buy | Microsoft Corp | $298,000 | -99.8% | 4,793 | +52.6% | 0.06% | +96.6% |
| IBM | Buy | IBM Corp | $293,000 | -99.8% | 1,766 | +54.5% | 0.06% | +93.1% |
| XOM | Buy | Exxon Mobil Corp | $288,000 | -99.8% | 3,195 | +52.0% | 0.06% | +89.7% |
| QCOM | Buy | Qualcomm Inc | $269,000 | -99.9% | 4,126 | +43.8% | 0.05% | +67.7% |
| F | Buy | Ford Motor Co | $273,000 | -99.8% | 22,511 | +54.1% | 0.05% | +85.7% |
| HAL | Buy | Halliburton Co (Hg Co) | $267,000 | -99.9% | 4,931 | +16.5% | 0.05% | +70.0% |
| MRTX | Mirati Therapeutics Inc | $238,000 | -99.9% | 50,000 | 0.0% | 0.05% | -11.5% | |
| BUD | New | Anheuser-Busch InBev SA ADR spons repr 1 Share | $230,000 | – | 2,180 | +100.0% | 0.04% | – |
| OREXQ | Orexigen Therapeutics Inc | $209,000 | -99.9% | 120,000 | 0.0% | 0.04% | -36.5% | |
| CAT | Sell | Caterpillar Inc | $144,000 | -99.9% | 1,548 | -28.9% | 0.03% | -9.7% |
| ANTH | Sell | Anthera Pharmaceuticals Inc | $130,000 | -100.0% | 200,000 | -33.3% | 0.02% | -83.3% |
| OPHT | New | Ophthotech Corp | $116,000 | – | 23,920 | +100.0% | 0.02% | – |
| THLD | Threshold Pharmaceuticals | $89,000 | -99.9% | 201,537 | 0.0% | 0.02% | -22.7% | |
| VRX | Exit | Valeant Pharmaceuticals Inte | $0 | – | -50,000 | -100.0% | -0.20% | – |
| JNJ | Exit | Johnson & Johnson | $0 | – | -15,000 | -100.0% | -0.28% | – |
| RAD | Exit | Rite Aid Corp | $0 | – | -300,000 | -100.0% | -0.37% | – |
| COO | Exit | Cooper Cos Inc/The | $0 | – | -20,000 | -100.0% | -0.57% | – |
| CEMP | Exit | Cempra Inc | $0 | – | -161,000 | -100.0% | -0.62% | – |
| MCK | Exit | Mckesson Corp | $0 | – | -25,000 | -100.0% | -0.66% | – |
| Exit | Anthem Inc | $0 | – | -67,434 | -100.0% | -1.34% | – | |
| Exit | Medtronic Plc | $0 | – | -169,078 | -100.0% | -2.32% | – | |
| Exit | Gilead Sciences Inc | $0 | – | -207,304 | -100.0% | -2.60% | – | |
| Exit | Pfizer Inc | $0 | – | -555,355 | -100.0% | -2.99% | – | |
| SHPG | Exit | Shire Plcsponsored adr | $0 | – | -409,858 | -100.0% | -4.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-01-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.